These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 8239628)
1. Comparison of fluconazole and amphotericin B for treatment of experimental Candida endocarditis caused by non-C. albicans strains. Witt MD; Imhoff T; Li C; Bayer AS Antimicrob Agents Chemother; 1993 Sep; 37(9):2030-2. PubMed ID: 8239628 [TBL] [Abstract][Full Text] [Related]
2. Comparison of fluconazole and amphotericin B for treatment of experimental Candida albicans endocarditis in rabbits. Chemlal K; Saint-Julien L; Joly V; Farinotti R; Seta N; Yeni P; Carbon C Antimicrob Agents Chemother; 1996 Jan; 40(1):263-6. PubMed ID: 8787921 [TBL] [Abstract][Full Text] [Related]
3. Efficacy of fluconazole in prophylaxis and treatment of experimental Candida endocarditis. Longman LP; Hibbert SA; Martin MV Rev Infect Dis; 1990; 12 Suppl 3():S294-8. PubMed ID: 2184507 [TBL] [Abstract][Full Text] [Related]
4. Comparison of fluconazole and amphotericin B in prophylaxis of experimental Candida endocarditis caused by non-C. albicans strains. Bayer AS; Witt MD; Kim E; Ghannoum MA Antimicrob Agents Chemother; 1996 Feb; 40(2):494-6. PubMed ID: 8834908 [TBL] [Abstract][Full Text] [Related]
5. Comparison of in vivo activity of fluconazole with that of amphotericin B against Candida tropicalis, Candida glabrata, and Candida krusei. Fisher MA; Shen SH; Haddad J; Tarry WF Antimicrob Agents Chemother; 1989 Sep; 33(9):1443-6. PubMed ID: 2554797 [TBL] [Abstract][Full Text] [Related]
6. Efficacies of high-dose fluconazole plus amphotericin B and high-dose fluconazole plus 5-fluorocytosine versus amphotericin B, fluconazole, and 5-fluorocytosine monotherapies in treatment of experimental endocarditis, endophthalmitis, and pyelonephritis due to Candida albicans. Louie A; Liu W; Miller DA; Sucke AC; Liu QF; Drusano GL; Mayers M; Miller MH Antimicrob Agents Chemother; 1999 Dec; 43(12):2831-40. PubMed ID: 10582868 [TBL] [Abstract][Full Text] [Related]
7. Comparison of fluconazole and amphotericin B for prevention and treatment of experimental Candida endocarditis. Witt MD; Bayer AS Antimicrob Agents Chemother; 1991 Dec; 35(12):2481-5. PubMed ID: 1810181 [TBL] [Abstract][Full Text] [Related]
8. In vivo activity of amphotericin B lipid complex in immunocompromised mice against fluconazole-resistant or fluconazole-susceptible Candida tropicalis. Warn PA; Morrissey J; Moore CB; Denning DW Antimicrob Agents Chemother; 2000 Oct; 44(10):2664-71. PubMed ID: 10991841 [TBL] [Abstract][Full Text] [Related]
9. Susceptibilities of Candida species to amphotericin B and fluconazole: the emergence of fluconazole resistance in Candida tropicalis. Yang YL; Ho YA; Cheng HH; Ho M; Lo HJ Infect Control Hosp Epidemiol; 2004 Jan; 25(1):60-4. PubMed ID: 14756222 [TBL] [Abstract][Full Text] [Related]
10. Combination therapy with amphotericin B and fluconazole against invasive candidiasis in neutropenic-mouse and infective-endocarditis rabbit models. Sanati H; Ramos CF; Bayer AS; Ghannoum MA Antimicrob Agents Chemother; 1997 Jun; 41(6):1345-8. PubMed ID: 9174196 [TBL] [Abstract][Full Text] [Related]
11. Activity of aminocandin (IP960) compared with amphotericin B and fluconazole in a neutropenic murine model of disseminated infection caused by a fluconazole-resistant strain of Candida tropicalis. Warn PA; Sharp A; Morrissey G; Denning DW J Antimicrob Chemother; 2005 Sep; 56(3):590-3. PubMed ID: 16046462 [TBL] [Abstract][Full Text] [Related]
13. Susceptibilities to amphotericin B and fluconazole of Candida species in Taiwan Surveillance of Antimicrobial Resistance of Yeasts 2006. Yang YL; Wang AH; Wang CW; Cheng WT; Li SY; Lo HJ; Diagn Microbiol Infect Dis; 2008 Jun; 61(2):175-80. PubMed ID: 18304773 [TBL] [Abstract][Full Text] [Related]
14. Susceptibility to thrombin-induced platelet microbicidal protein is associated with increased fluconazole efficacy against experimental endocarditis due to Candida albicans. Yeaman MR; Cheng D; Desai B; Kupferwasser LI; Xiong YQ; Gank KD; Edwards JE; Bayer AS Antimicrob Agents Chemother; 2004 Aug; 48(8):3051-6. PubMed ID: 15273120 [TBL] [Abstract][Full Text] [Related]
15. Impact of the order of initiation of fluconazole and amphotericin B in sequential or combination therapy on killing of Candida albicans in vitro and in a rabbit model of endocarditis and pyelonephritis. Louie A; Kaw P; Banerjee P; Liu W; Chen G; Miller MH Antimicrob Agents Chemother; 2001 Feb; 45(2):485-94. PubMed ID: 11158745 [TBL] [Abstract][Full Text] [Related]
16. The comparative efficacy of cilofungin, fluconazole and amphotericin B in disseminated Candida tropicalis infection in neutropenic mice. Fong IW; Bannatyne RM; Cheng PC Clin Invest Med; 1992 Oct; 15(5):434-9. PubMed ID: 1458716 [TBL] [Abstract][Full Text] [Related]
17. Fluconazole plus cyclosporine: a fungicidal combination effective against experimental endocarditis due to Candida albicans. Marchetti O; Entenza JM; Sanglard D; Bille J; Glauser MP; Moreillon P Antimicrob Agents Chemother; 2000 Nov; 44(11):2932-8. PubMed ID: 11036003 [TBL] [Abstract][Full Text] [Related]
18. Effects of amphotericin B and fluconazole on the extracellular and intracellular growth of Candida albicans. van Etten EW; van de Rhee NE; van Kampen KM; Bakker-Woudenberg IA Antimicrob Agents Chemother; 1991 Nov; 35(11):2275-81. PubMed ID: 1804000 [TBL] [Abstract][Full Text] [Related]
19. [Successful medical treatment of Candida tropicalis in prosthetic valve endocarditis]. Roel JE; Gamba A; Curone M; Pescio A; Bruno C; Finquelievich J Medicina (B Aires); 1998; 58(3):301-2. PubMed ID: 9713102 [TBL] [Abstract][Full Text] [Related]
20. Efficacies of fluconazole, caspofungin, and amphotericin B in Candida glabrata-infected p47phox-/- knockout mice. Ju JY; Polhamus C; Marr KA; Holland SM; Bennett JE Antimicrob Agents Chemother; 2002 May; 46(5):1240-5. PubMed ID: 11959551 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]